Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Creative Commons License

Korkmaz P., CAGLAN F. C., AYKIN N., NAZ H., TOKA O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.22, no.3, pp.92-96, 2016 (ESCI) identifier


Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy.